BioSpace News Archive

Business

Therapeutic Solutions International Announces Launch of Cancer Immunotherapy Spin-Off Res Nova Bio, Inc.

Therapeutic Solutions International (TSOI) announced today formation of a Spin-Off Company, Res Nova Bio, Inc., dedicated to the development of cancer inhibiting anti-angiogenesis immunotherapies.

October 27, 2022
·
2 min read
Business

CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2022 results on Thursday, November 10, 2022, after the market close.

October 27, 2022
·
1 min read
Deals

Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty

Agios Pharmaceuticals, Inc. and Sagard Healthcare Partners announced that Agios has sold its rights to 5% royalties on U.S. net sales of Servier’s TIBSOVO® to Sagard for a one-time payment of $131.8 million.

October 27, 2022
·
6 min read
Business

Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022

Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter of 2022 after the close of trading on Thursday, November 10, 2022.

October 27, 2022
·
1 min read
Business

Insmed Ranks No. 1 on Science’s 2022 Top Biopharma Employers List

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced that it has earned the highest ranking in Science’s 2022 Top Employers Survey.

October 27, 2022
·
2 min read
Business

Seagen Reports Third Quarter 2022 Financial Results

Seagen Inc. (Nasdaq:SGEN) reported financial results today for the third quarter ended September 30, 2022.

October 27, 2022
·
16 min read
Business

Gilead Sciences Announces Third Quarter 2022 Financial Results

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter of 2022.

October 27, 2022
·
35 min read
Business

Ignyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak Bio

Ignyte Acquisition Corp. today announced that Ignyte’s stockholders have approved its proposed business combination (the “Business Combination”) with Peak Bio Co., Ltd. (“Peak Bio”) at a Special Meeting of its stockholders held on October 25, 2022 (the “Special Meeting”).

October 27, 2022
·
8 min read
Business

CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Lawrence Klein, Ph.D., will be stepping down from the Company to pursue external opportunities.

October 27, 2022
·
4 min read
Business

Rigel Announces Conference Call and Webcast to Report Third Quarter 2022 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2022 financial results after market close on Thursday, November 3, 2022.

October 27, 2022
·
1 min read